The United Arab Emirates (UAE) has a well-regulated pharmaceutical industry to ensure the safety, efficacy, and quality of medicines. Companies operating in this sector must comply with strict legal procedures, including licensing, health regulations, and import/export controls.
1. Licensing Requirements
Key regulatory bodies include the Ministry of Health and Prevention (MOHAP), the Dubai Health Authority (DHA), the Abu Dhabi Department of Health (DOH), and the Emirates Authority for Standardization and Metrology (ESMA).
Types of licenses required: Pharmaceutical Manufacturing License for companies producing medicines locally; Pharmaceutical Distribution License for wholesalers; Pharmacy License for retail pharmacies; and Drug Registration — all medicines must be approved by MOHAP before sale.
The application process requires submitting company documents (trade license, facility details), providing product details including formulation, safety data, and clinical trials, undergoing facility inspections, and paying applicable fees.
2. Compliance with Health Regulations
Good Manufacturing Practices (GMP): Pharmaceutical manufacturers must adhere to GMP standards set by MOHAP and international bodies like the WHO and FDA.
Good Distribution Practices (GDP): Distributors must follow GDP guidelines to ensure proper storage and transportation of medicines.
Labeling and Packaging Regulations: Drug labels must include product name, active ingredients, dosage, manufacturer details, and expiry date. Arabic and English labeling is mandatory.
Pharmacovigilance & Adverse Drug Reporting: Companies must report adverse drug reactions to MOHAP. Continuous monitoring of drug safety is required post-approval.
3. Import/Export Controls
Import Procedures: Medicines must be registered with MOHAP before import. Customs clearance requires import permits, certificates of analysis, and invoices. Narcotics and psychotropic drugs require additional approvals from the UAE's National Rehabilitation Center (NRC).
Export Procedures: Obtain an export license from MOHAP, ensure compliance with the destination country's regulations, and provide necessary documentation including a Certificate of Pharmaceutical Product (CPP).
Free Zones: Dubai Healthcare City (DHCC) and Abu Dhabi's Masdar City offer streamlined licensing but still require MOHAP approval for drug distribution.
Conclusion
The UAE's pharmaceutical industry is highly regulated to maintain high standards of patient safety and product quality. Companies must ensure proper licensing, compliance with health regulations, and adherence to import/export controls.
For further guidance, contact Al Safar and Partners on 0527583267.
For further assistance or information please find out how our experts at Al Safar & Partners can help. Call +971 4 4221944 or email reception@alsafarpartners.com to get started.